Mary Kay Fenton
2012 - Achillion Pharmaceuticals
In 2012, Mary Kay Fenton earned a total compensation of $1.4M as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 67% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $138,176 |
|---|---|
| Option Awards | $922,084 |
| Salary | $300,800 |
| Other | $7,833 |
| Total | $1,368,893 |
Fenton received $922.1K in option awards, accounting for 67% of the total pay in 2012.
Fenton also received $138.2K in non-equity incentive plan, $300.8K in salary and $7.8K in other compensation.
Rankings
In 2012, Mary Kay Fenton's compensation ranked 4,905th out of 11,487 executives tracked by ExecPay. In other words, Fenton earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,905 out of 11,487 | 57th |
Division Manufacturing | 1,716 out of 4,253 | 60th |
Major group Chemicals And Allied Products | 404 out of 1,198 | 66th |
Industry group Drugs | 258 out of 920 | 72nd |
Industry Pharmaceutical Preparations | 203 out of 700 | 71st |
Source: SEC filing on April 17, 2015.
Fenton's colleagues
We found four more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2012.
2012
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
2012
Gautam Shah
Achillion Pharmaceuticals
Former Executive Vice President and Chief Compliance Officer
2012
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2012
Joseph Truitt
Achillion Pharmaceuticals